Overview
Lobbying Costs
435,000€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
5 Fte (6)
Lobbyists with EP accreditation
6
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
CONCILIUS AG
EU Transparency Register
695550548409-69 First registered on 16 Dec 2022
Goals / Remit
CONCILIUS advises companies, associations and other social actors at the interfaces with politics and administration in Germany and with the institutions of the European Union. With offices not only in Berlin and Brussels, but also in Munich, Stuttgart, Dusseldorf and Hamburg, we are able to address the special requirements of the federal political system in the best possible way. In addition to our services at EU, federal and state level, our clients value our expertise in supporting projects at the municipal level. Our consultants have excellent references and decades of experience in successfully dealing with regulatory issues in almost every industry sector. We emphasise a comprehensible, analysis-based and content- and target-oriented approach.
CONCILIUS was founded in 2003 and is still managed by its owners.Main EU files targeted
European Standardization Strategy; New Legislative Framework; Ecodesign for Sustainable Products – Product priorities; European Critical Raw Materials Act; Cyber Resilience Act; Artificial Intelligence Act; Standard Essential Patents; Construction Products Regulation; European Strategy for Data; EU Hydrogen Strategy; Digital Product Passport; Smart Farming; Cybersecurity; Malamud Case; Toy Safety Regulation; Right to Repair; Circular Economy Action Plan; European Green Deal; Batteries and waste batteries; Directive amending the Renewable Energy, Energy Performance of Buildings and Energy Efficiency Directives; EU space strategy for security and defence; Empowering consumers for the green transition; Establishing a European Bank for Hydrogen; Establishing the Single Market Emergency Instrument; European Chips Act; European Digital Identity; European Health Data Space; Industrial Emissions Directive; Cyber Solidarity Act; Proposal for a revision of EU legislation on Packaging and Packaging Waste; Clean Tech Act; Renewable Energy Directive; Alternative Fuel Infrastructure Regulation; Corporate Due Diligence Directive; Data Act; Product Liability Directive and Artificial Product Liability Directive; Electricity Market Design Reform; Renewable Energy Directive II: Access to vehicle data, functions and resources; Road Safety Package (autonomous diving maybe included); Euro 7; Industrial Green Deal; Net Zero Industry Act; Energy Taxation Directive; Payment Service Directive; Green Transport Package; EU Emissions Trading System; Carbon Border Adjustment Mechanism; Regulation on the approval and market surveillance of motor vehicles and their trailers, and of systems, components and separate technical units intended for such vehicles TEN-T; Digital Battery Pass; Autonomous Driving; Electric Vehicles; General Product Safety Regulation; Market Surveillance Regulation; Online fairness/dark patterns/withdrawals; Digital Services Act; Consumer Protection Cooperation Regulation; Alternative and Online Dispute Resolution Directive and Regulation; Vertical Block Exemption Regulation; Regulation on classification, labelling, and packaging of chemicals; Registration, Evaluation, Authorization and Restriction of Chemicals; Detergents Regulation; Cosmetic Products Regulation; Intellectual Property Enforcement Directive; Empowering Consumers for the Green Transition Directive; Green Claims Directive; Corporate Sustainability Due Diligence Directive; Forced Labour Regulation; Corporate Sustainability Reporting Directive; EU Taxonomy; CountEmissionsEU initiative; CO2 emission standards for trucks regulation; Sustainable Consumption of Goods initiative; EcoDesign Directive; Regulation on the Certification of Carbon Removals; VAT in the digital age Package; EU Customs Reform initiative; Anti-Money Laundering Regulation; Instant Payments Regulation; Digital Euro; eIDAS; Regulation on Horizontal Cybersecurity Requirements for Products with Digital Elements; Directive on Platform Work; EU Pharma Regulation; Artificial Intelligence Liability Directive; Secure Satellite Connectivity (IRIS2) implementation; Space Traffic Management Strategy and Space Law; Fair Share/ Network Tax policy; Regulation on Child Sexual Abuse Material (CSAM); Gigabit Infrastructure Act; Directive on improving working conditions in platform work; Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; Health Emergency Preparedness and Response Authority (HERA); Patent Package – SPC/uPSC for medicinal products, compulsory licensing; ‘Healthier Together’ Non Communicable Diseases plan; Industrial Strategy, Important Projects of Common European Interest (IPCEI) on health; Pharmaceutical Strategy; International Trade; International Health Regulations; WHO Pandemic Treaty – TRIPS waiver; EU-US relations;Non-communicable diseases, especially Diabetes, Alzheimer’s and Obesity.
Address
Head Office
Hermann-Sack-Strasse 3
Munich 80331
GERMANYEU Office
CONCILIUS Europe SRLAvenue de Cortenbergh 52
Brussels 1000
BELGIUMWebsite
-
People
Total lobbyists declared
6
Employment time Lobbyists 100% 4 75% 1 25% 1 Lobbyists (Full time equivalent)
5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
6 accreditations were / are live (in bold) for the selected state of 26 Dec 2024
Name Start date End Date Markus Russ 01 Nov 2024 30 Oct 2025 Arianna COLAIUTA 01 Nov 2024 30 Oct 2025 Lennart Dröge 01 Nov 2024 30 Oct 2025 Timothy MORRIS 01 Nov 2024 30 Oct 2025 Marta DAKIC 01 Nov 2024 30 Oct 2025 Sophie Löw 01 Nov 2024 30 Oct 2025 Sophie LOEW 22 Feb 2024 04 Oct 2024 Timothy MORRIS 22 Feb 2024 04 Oct 2024 Marta DAKIC 22 Feb 2024 04 Oct 2024 Arianna COLAIUTA 22 Feb 2024 04 Oct 2024 Lennart DROEGE 22 Feb 2024 04 Oct 2024 Sophie LOEW 30 Mar 2023 22 Feb 2024 Lennart DROEGE 23 Feb 2023 22 Feb 2024 Marta DAKIC 21 Feb 2023 21 Feb 2024 Arianna COLAIUTA 21 Feb 2023 21 Feb 2024 Ms Mirjam FRAKULLA 21 Feb 2023 21 Feb 2024 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Professional consultancies
-
Networking
Affiliation
American Chamber of Commerce in Germany e.V.
de'ge'pol - Deutsche Gesellschaft für Politikberatung e.V.
Deutsche Gesellschaft für Auswärtige Politik e. V.
DEUTSCHE GESELLSCHAFT FÜR WEHRTECHNIK e. V. (DWT)
Förderkreis Deutsches Heer e.V.
Forum Luft- und Raumfahrt e.V.
Wirtschaftsforum der SPD e.V.
Wirtschaftsbeirat Bayern - Wirtschaftsbeirat der Union e.V.
Wirtschaftsrat der CDU e. V.Member organisations
None declared
-
Financial Data
Interests represented
Advances interests of their clients
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
435,000€
Major contributions in closed year
None declared
Clients for closed financial year
Clients list
Name Proposal Amount alexion pharmaceuticals Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; European Health Data Space and its interplay with other digital legislation such as GDPR, Data Act; Clinical trials regulation; EU HTA regulation; Intellectual Property Rights and Incentives; Pharmaceutical strategy; EU Beating Cancer Plan; Regulation on the safety and quality of substances of human origin (SoHO); Health Emergency Preparedness and Response Authority (HERA) 100,000€ - 199,999€ Eli Lilly and Company Revision of the General Pharmaceutical Legislation; Revision of the Orphan Medicinal Products Legislation; Patent Package – SPC/uPSC for medicinal products, compulsory licensing; Beating Cancer Plan; European Health Data Space, and its interplay with other digital legislation such as GDPR, Data Act; EMA Fees regulation; ‘Healthier Together’ Non-Communicable Diseases plan; Intellectual Property Rights and Incentives; Industrial Strategy, Important Projects of Common European Interest (IPCEI) on health; Pharmaceutical Strategy; International Trade; International Health Regulations; Clinical trials regulation; WHO Pandemic Treaty – TRIPS waiver; EU-US relations; Non-communicable diseases, especially Diabetes, Alzheimer’s and Obesity 50,000€ - 99,999€ din deutsches institut für normung e. v. European Standardization Strategy; New Legislative Framework; Ecodesign for Sustainable Products – Product priorities; European Critical Raw Materials Act; Cyber Resilience Act; Artificial Intelligence Act; Standard Essential Patents; Construction Products Regulation; European Strategy for Data; EU Hydrogen Strategy; Digital Product Passport; Smart Farming; Cybersecurity; Malamud Case; Construction Product Regulation; Toy Safety Regulation; Right to Repair; Circular Economy Action Plan; European Green Deal; Batteres and waste batteries; Directive amending the Renewable Energy, Energy Performgance of Buildings and Energy Efficiency Directives; EU space strategy for security and defence; Ecodesign for Sustainable Products Regulation; Empowering consumers for the green transition; Establishing a European Bank for Hydrogen; Establishing the Single Market Emergency Instrument; European Chips Act; European Digital Identity; European Health Data Space; Industrial Emissions Directive (...) 50,000€ - 99,999€ Amazon Europe Core SARL General Product Safety Regulation; Product Liability Directive; Market Surveillance Regulation; Online fairness/dark patterns/withdrawals; Digital Services Act; Consumer Protection Cooperation Regulation; Alternative and Online Dispute Resolution Directive and Regulation; Vertical Block Exemption Regulation; Toy Safety Directive; Regulation on classification, labelling, and packaging of chemicals; Registration, Evaluation, Authorization and Restriction of Chemicals; Detergents Regulation; Cosmetic Products Regulation; Intellectual Property Enforcement Directive; Regulation on Standards Essential Patents; Empowering Consumers for the Green Transition Directive; Green Claims Directive; Corporate Sustainability Due Diligence Directive; Forced Labour Regulation; Corporate Sustainability Reporting Directive; EU Taxonomy; Alternative Fuels Infrastructure Regulation; CountEmissionsEU initiative; CO2 emission standards for trucks regulation; Packaging and Packaging Waste Regulation (...) 50,000€ - 99,999€ dahag rechtsservices ag Directive on improving working conditions in platform work 50,000€ - 99,999€ BASF SE Cosmetic Products Regulation (CPR) 50,000€ - 99,999€ daiichi sankyo europe gmbh Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; European Health Data Space and its interplay with other digital legislation such as GDPR, Data Act; Clinical trials regulation; EU HTA regulation; Intellectual Property Rights and Incentives; Pharmaceutical strategy; EU Beating Cancer Plan; Regulation on the safety and quality of substances of human origin (SoHO); Health Emergency Preparedness and Response Authority (HERA); Urban Wastewater Treatment Directive (UWWTD) 25,000€ - 49,999€ Bolt Platform Workers Directive, VAT in the Digital Age, Sustainable and Smart Mobility Strategy, Greening corporate fleets 25,000€ - 49,999€ nio gmbh Alternative Fuel Infrastructure Regulation; Corporate Due Diligence Directive; Artificial Intelligence Act; Data Act; Critical Raw Materials Act; Cyber Resilience Act; Regulation on Batteries and waste Batteries; Product Liability Directive and Artificial Product Liability Directive; Electricity Market Design Reform; Renewable Energy Directive II: Access to vehicle data, functions and resources; Road Safety Package (autonomous diving maybe included); Euro 7; Industrial Green Deal; Net Zero Industry Act; Energy Taxation Directive; Payment Service Directive; Green Transport Package; EU Emissions Trading System; Carbon Border Adjustment Mechanism; Regulation on the approval and market surveillance of motor vehicles and their trailers, and of systems, components and separate technical units intended for such vehicles TEN-T; Digital Battery Pass; Autonomous Driving; Electric Vehicles 25,000€ - 49,999€ European Confederation of Pharmaceutical Entrepreneurs Revision of the General Pharmaceutical Legislation; Revision of Orphan Medicinal Products Legislation; EMA Fees regulation; Cross border Healthcare directive; European Health Data Space and its interplay with other digital legislation such as GDPR, Data Act; Clinical trials regulation; EU HTA regulation; Intellectual Property Rights and Incentives; Pharmaceutical strategy; EU Beating Cancer Plan; Regulation on the safety and quality of substances of human origin (SoHO); Health Emergency Preparedness and Response Authority (HERA) 10,000€ - 24,999€ Clients for current financial year
Clients list
Name Eli Lilly and Company Amazon Europe Core SARL alexion pharmaceuticals din deutsches institut für normung e. v. European Confederation of Pharmaceutical Entrepreneurs Bolt Other financial info
None declared
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Conference, virtual events, virtual and non-virtual meetings, report on annual activities
Other activities
None declared
- Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 22 Nov 2022 Location Webex Subject Meeting with OD Expert Group on rare diseases, including EURORDIS, EUCOPE, Chiesi, EJP RD and Copenhagen Economics Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
- Meetings